Cargando…

Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection

Waning humoral immunity after mRNA vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a significant problem for public health. Breakthrough infection in hospitals over several months after vaccination has not been fully characterized, especially against the delta (B....

Descripción completa

Detalles Bibliográficos
Autores principales:	Goto, Takeyuki, Tani, Naoki, Ikematsu, Hideyuki, Gondo, Kei, Oishi, Ryo, Minami, Junya, Onozawa, Kyoko, Kuwano, Hiroyuki, Akashi, Koichi, Shimono, Nobuyuki, Chong, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312404/ https://www.ncbi.nlm.nih.gov/pubmed/35877668 http://dx.doi.org/10.1371/journal.pone.0272056

Ejemplares similares

No significant influence of pre-vaccination antipyretic use on specific antibody response to a BNT162b2 vaccine booster against COVID-19
por: Tani, Naoki, et al.
Publicado: (2022)

Relation of fever intensity and antipyretic use with specific antibody response after two doses of the BNT162b2 mRNA vaccine
por: Tani, Naoki, et al.
Publicado: (2022)

Correlation of Postvaccination Fever With Specific Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Booster and No Significant Influence of Antipyretic Medication
por: Tani, Naoki, et al.
Publicado: (2022)

Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents
por: Chong, Yong, et al.
Publicado: (2022)

Pronounced antibody elevation after SARS‐CoV‐2 BNT162b2 mRNA booster vaccination in nursing home residents
por: Chong, Yong, et al.
Publicado: (2022)

Achievement of sufficient antibody response after a fourth dose of wild‐type SARS‐CoV‐2 mRNA vaccine in nursing home residents
por: Chong, Yong, et al.
Publicado: (2023)

Genetic testing and serological screening for SARS-CoV-2 infection in a COVID-19 outbreak in a nursing facility in Japan
por: Chong, Yong, et al.
Publicado: (2021)

Breakthrough candidemia with hematological disease: Results from a single-center retrospective study in Japan, 2009–2020
por: Nishida, Ruriko, et al.
Publicado: (2023)

Invasive meningococcal disease due to a non-capsulated Neisseria meningitidis strain in a patient with IgG4-related disease
por: Kurose, Shun, et al.
Publicado: (2018)

Clinical significance of SARS‐CoV‐2‐specific IgG detection with a rapid antibody kit for COVID‐19 patients
por: Chong, Yong, et al.
Publicado: (2020)

An Immunocompetent Case of Capnocytophaga canimorsus Infection Complicated by Secondary Thrombotic Microangiopathy and Disseminated Intravascular Coagulation
por: Tani, Naoki, et al.
Publicado: (2019)

Nosocomial Outbreak by Delta Variant From a Fully Vaccinated Patient
por: Jung, Jiwon, et al.
Publicado: (2022)

A fatal case of COVID‐19 breakthrough infection due to the delta variant
por: Bignardi, Elio, et al.
Publicado: (2022)

Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses
por: Walls, Alexandra C., et al.
Publicado: (2021)

Helicobacter cinaedi Bacteremia Mimicking a Flare of Systemic Lupus Erythematosus
por: Nishida, Ruriko, et al.
Publicado: (2017)

Platypnea-Orthodeoxia Syndrome in Coronavirus Disease 2019 Pneumonia: A Case Report and Literature Review
por: Tanimoto, Takahiko, et al.
Publicado: (2023)

Fending off Delta – Hospital measures to reduce nosocomial transmission of COVID-19
por: LIM, Rachel Hui Fen, et al.
Publicado: (2022)

Investigation of vaccine breakthrough infections by vaccination scheme during the Delta variant wave in France
por: Bal, Antonin, et al.
Publicado: (2022)

Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections
por: Zou, Jing, et al.
Publicado: (2022)

Protection Against Breakthrough Delta/Omicron Variants in Vaccinated Patients with Myeloproliferative Neoplasms (MPN)
por: Barbui, Tiziano, et al.
Publicado: (2022)

Evaluation of Neutralizing Activity against Omicron Subvariants in BA.5 Breakthrough Infection and Three-Dose Vaccination Using a Novel Chemiluminescence-Based, Virus-Mediated Cytopathic Assay
por: Toyoda, Mako, et al.
Publicado: (2023)

Antibiotic Rotation for Febrile Neutropenic Patients with Hematological Malignancies: Clinical Significance of Antibiotic Heterogeneity
por: Chong, Yong, et al.
Publicado: (2013)

Decreased memory B cell frequencies in COVID‐19 delta variant vaccine breakthrough infection
por: Tay, Matthew Zirui, et al.
Publicado: (2022)

SARS-CoV-2 Delta Variant Breakthrough Infection and Onward Secondary Transmission in Household
por: Yi, Seonju, et al.
Publicado: (2021)

A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant
por: Zhang, Mengxin, et al.
Publicado: (2022)

Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
por: Hsu, L., et al.
Publicado: (2022)

Clinical and genomic signatures of SARS-CoV-2 Delta breakthrough infections in New York
por: Duerr, Ralf, et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA
por: Keyel, Alexander C., et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
por: Regenhardt, Elisa, et al.
Publicado: (2023)

Dynamics of anti-Spike IgG antibody level after the second BNT162b2 COVID-19 vaccination in health care workers
por: Ikezaki, Hiroaki, et al.
Publicado: (2022)

Dynamics of anti-spike IgG antibody after a third BNT162b2 COVID-19 vaccination in Japanese health care workers
por: Ikezaki, Hiroaki, et al.
Publicado: (2022)

Impact of peripheral mitochondrial DNA level on immune response after COVID-19 vaccination
por: Ikezaki, Hiroaki, et al.
Publicado: (2023)

Atrial flutter with an epicardial and endocardial breakthrough in the cavotricuspid isthmus
por: Kobayashi, Shuhei, et al.
Publicado: (2021)

Severe SARS-CoV-2 Breakthrough Reinfection With Delta Variant After Recovery From Breakthrough Infection by Alpha Variant in a Fully Vaccinated Health Worker
por: Shastri, Jayanthi, et al.
Publicado: (2021)

Clinical Impact of Fluoroquinolone-Resistant Escherichia coli in the Fecal Flora of Hematological Patients with Neutropenia and Levofloxacin Prophylaxis
por: Chong, Yong, et al.
Publicado: (2014)

Risk Factors Associated with Stenotrophomonas maltophilia Bacteremia: A Matched Case-Control Study
por: Sumida, Kosuke, et al.
Publicado: (2015)

Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections
por: Farinholt, Timothy, et al.
Publicado: (2021)

An Outbreak of Breakthrough Infections by the SARS-CoV-2 Delta Variant in a Psychiatric Closed Ward
por: Wi, Yu Mi, et al.
Publicado: (2022)

Transmission event of SARS-CoV-2 Delta variant reveals multiple vaccine breakthrough infections
por: Farinholt, Timothy, et al.
Publicado: (2021)

Clinical and genomic signatures of rising SARS-CoV-2 Delta breakthrough infections in New York
por: Duerr, Ralf, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a4t43tdfgpdgi8rr00cgbtbqa1